+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Inflammatory Bowel Disease Drug"

From
From
From
Inflammatory Bowel Disease Market 2024-2028 - Product Thumbnail Image

Inflammatory Bowel Disease Market 2024-2028

  • Report
  • May 2024
  • 170 Pages
  • Global
From
From
Crohn's Disease (CD) Treatment Market Report 2025 - Product Thumbnail Image

Crohn's Disease (CD) Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Interleukin Inhibitors Market Report and Forecast 2024-2032 - Product Thumbnail Image

Interleukin Inhibitors Market Report and Forecast 2024-2032

  • Report
  • July 2024
  • 200 Pages
  • Global
From
Autoimmune Drugs Market 2024-2028 - Product Thumbnail Image

Autoimmune Drugs Market 2024-2028

  • Report
  • July 2024
  • 185 Pages
  • Global
From
From
From
From
From
From
Loading Indicator

The Immune Disorders Drugs market includes drugs used to treat Inflammatory Bowel Disease (IBD). IBD is a chronic condition that causes inflammation of the digestive tract, leading to abdominal pain, diarrhea, and other symptoms. IBD drugs are used to reduce inflammation and improve symptoms. These drugs include corticosteroids, immunomodulators, biologics, and other medications. Corticosteroids are used to reduce inflammation and suppress the immune system, while immunomodulators are used to modify the immune system's response to inflammation. Biologics are used to target specific molecules involved in the inflammatory process. Some companies in the IBD drug market include AbbVie, Amgen, AstraZeneca, Boehringer Ingelheim, Janssen, Merck, Pfizer, and Takeda. Show Less Read more